Gene · 3491
Papers4,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCN1 derived from vascular endothelial cells impairs cognitive function in Alzheimer's disease model mice. | J Pharmacol Sci | 2025 | 39929589 | PubTator, text mining | PubMed |
| Cellular senescence-associated genes in rheumatoid arthritis: Identification and functional analysis. | PLoS One | 2025 | 39820552 | PubTator, text mining | PubMed |
| CCN1 promotes APRIL/BAFF signaling in esophageal squamous cell carcinoma but attenuates it in esophageal adenocarcinoma. | Sci Rep | 2025 | 39806221 | PubTator, text mining | PubMed |
| Development of a Novel four-gene Model for Monitoring the Progression from Metabolic Dysfunction-associated Steatotic Liver Disease to Hepatocellular Carcinoma in Males. | J Cancer | 2025 | 39781352 | PubTator, text mining | PubMed |
| Paeoniflorin sensitizes imatinib mesylate-resistant chronic myeloid leukemia cells via the inhibition of Cyr61 production. | Anticancer Drugs | 2025 | 39773616 | PubTator, text mining | PubMed |
| Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis. | Brain | 2025 | 39718981 | PubTator, text mining | PubMed |
| USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1. | Neoplasia | 2025 | 39674114 | PubTator, text mining | PubMed |
| [The Correlation of Serum CMTM6 and CCN1 Expression with Clinical Efficacy and Prognosis of Patients with Acute Leukemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39743247 | PubTator, text mining | PubMed |
| A Role for the Hippo/YAP1 Pathway in the Regulation of In Vitro Vasculogenic Mimicry in Glioblastoma Cells. | J Cell Mol Med | 2024 | 39718433 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis reveals novel insights into osteoarthritis pathogenesis and diagnostic biomarkers. | BMC Musculoskelet Disord | 2024 | 39639239 | PubTator, text mining | PubMed |
| CYR61 Is Overexpressed in Human Melanoma Tissue Ex Vivo and Promotes Melanoma Cell Survival and Proliferation Through Its Binding Ligand Integrin β3 In Vitro. | Ann Dermatol | 2024 | 39623617 | PubTator, text mining | PubMed |
| CYR61 as a Potential Apoptosis Biomarker in Osteoarthritis with Comorbidities. | J Musculoskelet Neuronal Interact | 2024 | 39616508 | PubTator, text mining | PubMed |
| Genes Related to Motility in an Ionizing Radiation and Estrogen Breast Cancer Model. | Biology (Basel) | 2024 | 39596804 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase RNF6 facilitates the progression of cervical cancer by inhibiting the Hippo/Yap pathway. | Cell Div | 2024 | 39551725 | PubTator, text mining | PubMed |
| Cellular communication network 1 promotes CASP2 mRNA expression but suppresses its protein translation in esophageal adenocarcinoma. | J Cell Commun Signal | 2024 | 39524140 | PubTator, text mining | PubMed |
| Pan-Transcriptional Enhanced Associated Domain Palmitoylation Pocket Covalent Inhibitor. | J Med Chem | 2024 | 39487823 | PubTator, text mining | PubMed |
| TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma. | Front Immunol | 2024 | 39430767 | PubTator, text mining | PubMed |
| Restoring social deficits in IRSp53-deleted mice: chemogenetic inhibition of ventral dentate gyrus Emx1-expressing cells. | Transl Psychiatry | 2024 | 39375329 | PubTator, text mining | PubMed |
| LRP1 Repression by SNAIL Results in ECM Remodeling in Genetic Risk for Vascular Diseases. | Circ Res | 2024 | 39355906 | PubTator, text mining | PubMed |
| Targeted degradation of specific TEAD paralogs by small molecule degraders. | Heliyon | 2024 | 39328531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3491/papers?page=9